Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
Plos One|April 23, 2015
Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In VitroMichael P Trombley, Deborah M B Post, Sherri D Rinker, et al.
BMC Neurology|November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-studyConstant V M Verschuur, S R Suwijn, B Post, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Journal of Animal Science|June 10, 2024
Effect of bone and analytical method on assessment of bone mineralization in response to dietary phosphorus, phytase, and vitamin D in finishing pigsHadley R Williams, Mike D Tokach, Jason C Woodworth, et al.
Gastroenterology|January 24, 2007
Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalitiesFlorian Rieder, Ling Cheng, Karen M Harnett, et al.
Plos One|July 14, 2010
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensisMichael A Apicella, Deborah M B Post, Andrew C Fowler, et al.
Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.
Pageof 31